Torrent Pharmaceuticals Overview
- Year Founded
-
1959
- Status
-
Public
- Employees
-
17,729
- Stock Symbol
-
TORNTPHARM
- Investments
-
21
- Share Price
-
$49.33
- (As of Thursday Closing)
Torrent Pharmaceuticals General Information
Description
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, Vitamins Minerals Nutrients (VMN), and gastrointestinal therapeutic areas. It operates through the Generic Formulation Business segment. Geographically, the business activities are carried out across Indian and International markets. Maximum revenue for the company is generated from its operations in India.
Contact Information
Website
www.torrentpharma.comCorporate Office
- Avirat, Thaltej Shilaj Road
- Ahmedabad, Gujarat 380059
- India
Corporate Office
- Avirat, Thaltej Shilaj Road
- Ahmedabad, Gujarat 380059
- India
Torrent Pharmaceuticals Stock Performance
As of 19-Nov-2026, Torrent Pharmaceuticals’s stock price is $49.33. Its current market cap is $18.8B with 380M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $49.33 | $49.33 | $40.26 - $55.03 | $18.8B | 380M | 318K | $0.64 |
Torrent Pharmaceuticals Financials Summary
As of 30-Sep-2026, Torrent Pharmaceuticals has a trailing 12-month revenue of $1.85B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 21,284,821 | 15,258,096 | 12,940,193 | 10,983,095 |
| Revenue | 1,845,360 | 1,556,406 | 1,338,413 | 1,275,859 |
| EBITDA | 605,579 | 490,829 | 437,447 | 421,396 |
| Net Income | 229,079 | 244,826 | 226,030 | 200,080 |
| Total Assets | 4,644,919 | 4,696,422 | 1,752,381 | 1,805,966 |
| Total Debt | 1,468,696 | 1,592,484 | 374,368 | 482,285 |
Torrent Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Torrent Pharmaceuticals Comparisons
Industry
Financing
Details
Torrent Pharmaceuticals Competitors (49)
One of Torrent Pharmaceuticals’s 49 competitors is Divi's Laboratories, a Corporation company based in Hyderabad, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Divi's Laboratories | Corporation | Hyderabad, India | ||||
| Alkem Laboratories | Formerly PE-Backed | Mumbai, India | ||||
| Ajanta Pharma | Corporation | Mumbai, India | ||||
| Granules India | Corporation | Hyderabad, India | ||||
| Cipla | Corporation | Mumbai, India |
Torrent Pharmaceuticals Patents
Torrent Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025163603-A1 | Direct resolution of desacetylketoconazole salt | Pending | 01-Feb-2024 | ||
| US-20260062411-A1 | Novel salt of substituted 5-fluoro-1h-pyrazolopyridines and its uses | Pending | 18-Aug-2022 | ||
| WO-2024038398-A1 | Novel salt of substituted 5-fluoro-1h-pyrazolopyridines and its uses | Inactive | 18-Aug-2022 | ||
| WO-2023047203-A1 | Combination of omzotirome and antidiabetic agent, antihypertensive agent or anti-dyslipidemic agent | Inactive | 25-Sep-2021 | ||
| WO-2023285981-A1 | Stable pharmaceutical liquid composition of nilotinib | Inactive | 15-Jul-2021 | A61K31/506 |
Torrent Pharmaceuticals Signals
Torrent Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Torrent Pharmaceuticals Investments & Acquisitions (21)
Torrent Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with Ruby Textiles Mills (Commercial Space on the 33rd Floor in Mumbai, India) for . The deal was made on 19-Aug-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Ruby Textiles Mills (Commercial Space on the 33rd Floor in Mumbai, India) | 19-Aug-2026 | Corporate Asset Purchase | Buildings and Property | ||
| J. B. Chemicals & Pharmaceuticals | 08-Jul-2026 | Merger/Acquisition | Pharmaceuticals | ||
| J. B. Chemicals & Pharmaceuticals | 21-Jan-2026 | Secondary Transaction - Private | Pharmaceuticals | ||
| Boehringer Ingelheim (Three Anti-diabetes Brands in Ingelheim Am Rhein, Germany) | 04-Dec-2024 | Corporate Asset Purchase | Buildings and Property | ||
| 23IKIGAI | 03-Oct-2024 | Later Stage VC | Drug Discovery |
Torrent Pharmaceuticals ESG
Risk Overview
Risk Rating
Updated November, 17, 2026
25.44 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Torrent Pharmaceuticals Exits (1)
Torrent Pharmaceuticals’s most recent exit was on 26-May-2022 from Dr Reddy's Laboratories (Styptovit-E, Finast, Finast-T and Dynapress Brands in Telangana, Hyderabad). The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Dr Reddy's Laboratories (Styptovit-E, Finast, Finast-T and Dynapress Brands in Telangana, Hyderabad) | 26-May-2022 | Completed |
|
Torrent Pharmaceuticals Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Zyg Pharma | Ahmedabad, India | 1987 | |
| J. B. Chemicals & Pharmaceuticals | Mumbai, India | 1976 | |
| Heumann Pharma | Nuremberg, Germany | 1913 |
Torrent Pharmaceuticals FAQs
-
When was Torrent Pharmaceuticals founded?
Torrent Pharmaceuticals was founded in 1959.
-
Where is Torrent Pharmaceuticals headquartered?
Torrent Pharmaceuticals is headquartered in Ahmedabad, India.
-
What is the size of Torrent Pharmaceuticals?
Torrent Pharmaceuticals has 17,729 total employees.
-
What industry is Torrent Pharmaceuticals in?
Torrent Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Torrent Pharmaceuticals a private or public company?
Torrent Pharmaceuticals is a Public company.
-
What is Torrent Pharmaceuticals’s stock symbol?
The ticker symbol for Torrent Pharmaceuticals is TORNTPHARM.
-
What is the current stock price of Torrent Pharmaceuticals?
As of 19-Nov-2026 the stock price of Torrent Pharmaceuticals is $49.33.
-
What is the current market cap of Torrent Pharmaceuticals?
The current market capitalization of Torrent Pharmaceuticals is $18.8B.
-
What is Torrent Pharmaceuticals’s current revenue?
The trailing twelve month revenue for Torrent Pharmaceuticals is $1.85B.
-
Who are Torrent Pharmaceuticals’s competitors?
Divi's Laboratories, Alkem Laboratories, Ajanta Pharma, Granules India, and Cipla are some of the 49 competitors of Torrent Pharmaceuticals.
-
What is Torrent Pharmaceuticals’s annual earnings per share (EPS)?
Torrent Pharmaceuticals’s EPS for 12 months was $0.64.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process